1. Efficacy and safety of a cisplatin and paclitaxel induction regimen followed by chemoradiotherapy for patients with locally advanced head and neck squamous cell carcinoma
   Luciano de Souza Viana et al, 2016, Head & Neck CrossRef
2. A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
   Tomohiro Enokida et al, 2020, Cancer Medicine CrossRef
3. Two cases of combination therapy with cetuximab, paclitaxel, and cisplatin for advanced head and neck cancer
   Matthew A Hoch et al, 2018, Journal of Oncology Pharmacy Practice CrossRef
4. Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk‐adapted adjuvant therapy for squamous cell carcinoma of the head and neck
   Jared M. Weiss et al, 2018, Cancer CrossRef
5. Is there a Role for Neoadjuvant Targeted Therapy and Immunotherapy?
   Simon Beyaert et al, 2021, Critical Issues in Head and Neck Oncology CrossRef
6. Chemotherapy advances in locally advanced head and neck cancer
   Peter Georges, 2014, World Journal of Clinical Oncology CrossRef
7. The Role of Chemotherapy in the Management of Patients with Locally Advanced Unresectable Head and Neck Cancer
   Tomohiro Enokida et al, 2013, Nihon Kikan Shokudoka Gakkai Kaiho CrossRef
8. Combination treatment with paclitaxel, carboplatin and cetuximab in maxillary sinus cancer: A case report
   Masahiro Morimoto et al, 2024, Oncology Letters CrossRef
9. Weekly Paclitaxel, Carboplatin, and Cetuximab as First-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma for Patients Ineligible to Cisplatin-Based Chemotherapy: A Retrospective Monocentric Study in 60 Patients
   Hélène Carinato et al, 2021, Frontiers in Oncology CrossRef
10. Induction chemotherapy in locally advanced head and neck cancers, is there a best choice?
    Hoda Mahdavi, 2023, Critical Reviews in Oncology/Hematology CrossRef
11. Evaluation of weekly paclitaxel, carboplatin, and cetuximab in head and neck cancer patients with incurable disease
    Lisa Narveson et al, 2016, Medical Oncology CrossRef
12. A Single-institution Comparison of Cetuximab, Carboplatin, and Paclitaxel Induction Chemotherapy Followed by Chemoradiation (CRT) Versus CRT for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN)
    Surbhi Grover et al, 2016, American Journal of Clinical Oncology CrossRef
13. Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care Therapy
    Alexander T. Murr et al, 2022, Otolaryngology–Head and Neck Surgery CrossRef
14. Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck
    Jared Weiss et al, 2018, Oral Oncology CrossRef
15. Efficacy and toxicity of weekly paclitaxel, carboplatin, and cetuximab as induction chemotherapy or in cases of metastases or relapse for head and neck cancer with a focus on elderly or frail patients
    Rebecca Forman et al, 2022, Head & Neck CrossRef
16. How Should We Approach Locally Advanced Squamous Cell Carcinoma of Head and Neck Cancer Patients Ineligible for Standard Non-surgical Treatment?
    Tomoya Yokota et al, 2020, Current Oncology Reports CrossRef
17. Induction chemotherapy for the individualised treatment of hypopharyngeal carcinoma with cervical oesophageal invasion: a retrospective cohort study
    Tian-Qiao Huang et al, 2020, World Journal of Surgical Oncology CrossRef
18. Usefulness of 64Cu-ATSM in Head and Neck Cancer
    Ilaria Grassi et al, 2014, Clinical Nuclear Medicine CrossRef
19. Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance
    Conner Belnap et al, 2024, International Journal of Molecular Sciences CrossRef
20. Alteronol induces cell cycle arrest and apoptosis via increased reactive oxygen species production in human breast cancer T47D cells
    Boxue Ren et al, 2018, Journal of Pharmacy and Pharmacology CrossRef
21. Induction chemotherapy in head and neck cancers: Results and controversies
    Max Gau et al, 2019, Oral Oncology CrossRef
22. Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinoma
    Siddharth Sheth et al, 2022, Oral Oncology CrossRef